Young LS - Search Results

1

TRAF6 is required for TRAF2-dependent CD40 signal transduction in nonhemopoietic cells.

Davies CC, Mak TW, Young LS, Eliopoulos AG. Davies CC, et al. Among authors: young ls. Mol Cell Biol. 2005 Nov;25(22):9806-19. doi: 10.1128/MCB.25.22.9806-9819.2005. Mol Cell Biol. 2005. PMID: 16260598 Free PMC article.

2

Constitutive activation of the CD40 pathway promotes cell transformation and neoplastic growth.

Baxendale AJ, Dawson CW, Stewart SE, Mudaliar V, Reynolds G, Gordon J, Murray PG, Young LS, Eliopoulos AG. Baxendale AJ, et al. Among authors: young ls. Oncogene. 2005 Nov 24;24(53):7913-23. doi: 10.1038/sj.onc.1208929. Oncogene. 2005. PMID: 16091748

3

The oncogenic protein kinase Tpl-2/Cot contributes to Epstein-Barr virus-encoded latent infection membrane protein 1-induced NF-kappaB signaling downstream of TRAF2.

Eliopoulos AG, Davies C, Blake SS, Murray P, Najafipour S, Tsichlis PN, Young LS. Eliopoulos AG, et al. Among authors: young ls. J Virol. 2002 May;76(9):4567-79. doi: 10.1128/jvi.76.9.4567-4579.2002. J Virol. 2002. PMID: 11932422 Free PMC article.

4

TRAF1 is a critical regulator of JNK signaling by the TRAF-binding domain of the Epstein-Barr virus-encoded latent infection membrane protein 1 but not CD40.

Eliopoulos AG, Waites ER, Blake SM, Davies C, Murray P, Young LS. Eliopoulos AG, et al. Among authors: young ls. J Virol. 2003 Jan;77(2):1316-28. doi: 10.1128/jvi.77.2.1316-1328.2003. J Virol. 2003. PMID: 12502848 Free PMC article.

5

Inhibition of phosphatidylinositol 3-kinase- and ERK MAPK-regulated protein synthesis reveals the pro-apoptotic properties of CD40 ligation in carcinoma cells.

Davies CC, Mason J, Wakelam MJ, Young LS, Eliopoulos AG. Davies CC, et al. Among authors: young ls. J Biol Chem. 2004 Jan 9;279(2):1010-9. doi: 10.1074/jbc.M303820200. Epub 2003 Oct 27. J Biol Chem. 2004. PMID: 14581487 Free article.

6

The role of the CD40 pathway in the pathogenesis and treatment of cancer.

Eliopoulos AG, Young LS. Eliopoulos AG, et al. Among authors: young ls. Curr Opin Pharmacol. 2004 Aug;4(4):360-7. doi: 10.1016/j.coph.2004.02.008. Curr Opin Pharmacol. 2004. PMID: 15251129 Review.

7

Activation of CD40 in cervical carcinoma cells facilitates CTL responses and augments chemotherapy-induced apoptosis.

Hill SC, Youde SJ, Man S, Teale GR, Baxendale AJ, Hislop A, Davies CC, Luesley DM, Blom AM, Rickinson AB, Young LS, Eliopoulos AG. Hill SC, et al. Among authors: young ls. J Immunol. 2005 Jan 1;174(1):41-50. doi: 10.4049/jimmunol.174.1.41. J Immunol. 2005. PMID: 15611226

8

NF-kappaB overrides the apoptotic program of TNF receptor 1 but not CD40 in carcinoma cells.

Davies CC, Bem D, Young LS, Eliopoulos AG. Davies CC, et al. Among authors: young ls. Cell Signal. 2005 Jun;17(6):729-38. doi: 10.1016/j.cellsig.2004.10.014. Epub 2004 Dec 7. Cell Signal. 2005. PMID: 15722197

9

Activation of the cJun N-terminal kinase (JNK) pathway by the Epstein-Barr virus-encoded latent membrane protein 1 (LMP1).

Eliopoulos AG, Young LS. Eliopoulos AG, et al. Among authors: young ls. Oncogene. 1998 Apr 2;16(13):1731-42. doi: 10.1038/sj.onc.1201694. Oncogene. 1998. PMID: 9582021

10

CD40 and epithelial cells: across the great divide.

Young LS, Eliopoulos AG, Gallagher NJ, Dawson CW. Young LS, et al. Immunol Today. 1998 Nov;19(11):502-6. doi: 10.1016/s0167-5699(98)01340-1. Immunol Today. 1998. PMID: 9818543 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

738 results

Search Page

Filters